Merrimack’s research and development programs are focused on the identification of innovative products that advance the treatment of autoimmune disease and cancer. We believe that the key to substantially safer and more effective therapeutics is a better understanding of the complex biology that underlies disease. To that end, we have developed a proprietary technology platform that enables the high throughput profiling of complex biological systems: Network Biology.

Network Biology represents a fully integrated solution to better, more efficient drug discovery and development that combines biology, engineering, and computational modeling. Rather than focus on individual molecular components, Network Biology seeks to understand the system dynamics that govern protein networks - the functional set of proteins that regulate cellular decisions. More than a research tool, Network Biology is a set of technologies designed to enhance the entire drug discovery, development, and commercialization process.

Our mission is to provide physicians and patients with the next generation of molecular medicines - the combination of a best-in-class targeted therapy with a molecular diagnostic – that enable physicians to provide treatment for each patient.

[ back to top ]